Phreesia (NYSE:PHR) Given Neutral Rating at Citigroup

Phreesia (NYSE:PHR)‘s stock had its “neutral” rating reiterated by equities research analysts at Citigroup in a research note issued to investors on Tuesday, Marketbeat reports. They currently have a $10.00 target price on the stock. Citigroup’s price objective points to a potential downside of 12.54% from the company’s current price.

A number of other analysts have also issued reports on the stock. JPMorgan Chase & Co. lowered their target price on shares of Phreesia from $29.00 to $24.00 and set an “overweight” rating for the company in a research note on Friday, February 20th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday, January 28th. Barclays decreased their price objective on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating for the company in a report on Tuesday, December 16th. Royal Bank Of Canada initiated coverage on shares of Phreesia in a research note on Friday, January 9th. They issued a “moderate buy” rating and a $26.00 target price on the stock. Finally, DA Davidson reduced their target price on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, January 23rd. Thirteen investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and an average target price of $22.71.

Phreesia Trading Up 4.1%

Shares of NYSE PHR opened at $11.43 on Tuesday. Phreesia has a fifty-two week low of $10.75 and a fifty-two week high of $32.76. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. The company has a market cap of $689.36 million, a price-to-earnings ratio of -114.33 and a beta of 0.67. The business’s 50 day moving average price is $12.51 and its 200-day moving average price is $17.68.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). The business had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. Phreesia’s revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.11) EPS. On average, sell-side analysts expect that Phreesia will post -1.1 earnings per share for the current year.

Insider Transactions at Phreesia

In related news, insider David Linetsky sold 6,038 shares of the company’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $98,781.68. Following the completion of the sale, the insider directly owned 223,942 shares of the company’s stock, valued at $3,663,691.12. This represents a 2.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 6,176 shares of the stock in a transaction dated Monday, March 23rd. The stock was sold at an average price of $11.97, for a total transaction of $73,926.72. Following the transaction, the general counsel owned 163,485 shares in the company, valued at approximately $1,956,915.45. The trade was a 3.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 70,358 shares of company stock valued at $1,123,569 over the last three months. 5.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Phreesia

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Phreesia by 8.3% during the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after acquiring an additional 437,462 shares during the last quarter. New York State Common Retirement Fund grew its holdings in Phreesia by 727.1% in the third quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock worth $3,219,000 after purchasing an additional 120,309 shares during the last quarter. Squarepoint Ops LLC increased its position in shares of Phreesia by 243.6% during the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares in the last quarter. Greenhouse Funds LLLP increased its position in shares of Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after purchasing an additional 557,265 shares in the last quarter. Finally, Bessemer Group Inc. lifted its holdings in shares of Phreesia by 1,065.9% during the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after purchasing an additional 506,954 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.